Tevogen Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Tevogen Inc. (TVGN) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$78.37 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-14
- Tevogen Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$419.97K, a 253.95% decline year-over-year.
- Tevogen Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $341.60K, a 1268.14% increase year-over-year.
- Tevogen Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$91.30K.
- Tevogen Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$308.30K.
- Tevogen Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$101.84K, a 141.40% decline from fiscal 2024.
- Tevogen Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $246.00K, a 22.54% decline from fiscal 2023.
- Tevogen Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $317.61K.
- Tevogen Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$446.61K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 8 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$419.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$78.37K 10-Q · filed 2026-08-14 | -$169.67K derived: sum of 3 quarters · filed 2026-08-14 | -$477.97K derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2026-03-31 | $341.60K 10-Q · filed 2026-05-15 | $250.30K derived: sum of 2 quarters · filed 2026-05-15 | -$58.00K derived: sum of 3 quarters · filed 2026-05-15 | $214.79K derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2025-12-31 | -$91.30K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$399.60K derived: sum of 2 quarters · filed 2026-03-31 | -$126.81K derived: sum of 3 quarters · filed 2026-08-14 | -$101.84K 10-K · filed 2026-03-31 | |||||
| 2025-09-30 | -$308.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$35.51K derived: sum of 2 quarters · filed 2026-08-14 | -$10.54K 10-Q · filed 2025-11-14 | -$129.67K derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2025-06-30 | $272.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $297.76K 10-Q · filed 2026-08-14 | $178.63K derived: sum of 3 quarters · filed 2026-08-14 | $64.30K derived: sum of 4 quarters · filed 2026-08-14 | |||||
| 2025-03-31 | $24.97K 10-Q · filed 2026-05-15 | -$94.16K derived: sum of 2 quarters · filed 2026-05-15 | -$208.50K derived: sum of 3 quarters · filed 2026-05-15 | $20.85K derived: sum of 4 quarters · filed 2026-05-15 | |||||
| 2024-12-31 | -$119.13K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$233.47K derived: sum of 2 quarters · filed 2026-03-31 | -$4.11K derived: sum of 3 quarters · filed 2026-03-31 | $246.00K 10-K · filed 2026-03-31 | |||||
| 2024-09-30 | -$114.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $115.02K derived: sum of 2 quarters · filed 2025-11-14 | $365.13K 10-Q · filed 2025-11-14 | $878.92K derived: sum of 4 quarters · filed 2025-11-14 | |||||
| 2024-06-30 | $229.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $479.47K 10-Q · filed 2025-08-14 | $993.26K derived: sum of 3 quarters · filed 2025-08-14 | $941.55K derived: sum of 4 quarters · filed 2025-08-14 | |||||
| 2024-03-31 | $250.12K 10-Q · filed 2025-05-14 | $763.90K derived: sum of 2 quarters · filed 2025-05-14 | $712.20K derived: sum of 3 quarters · filed 2025-05-14 | $638.28K derived: sum of 4 quarters · filed 2025-05-14 | |||||
| 2023-12-31 | $513.79K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-02 | $462.08K derived: sum of 2 quarters · filed 2025-04-02 | $388.16K derived: sum of 3 quarters · filed 2025-04-02 | $317.61K 10-K · filed 2025-04-02 | -$142.67K 10-K · filed 2024-04-29 | ||||
| 2023-09-30 | -$51.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-19 | -$125.63K derived: sum of 2 quarters · filed 2024-11-19 | -$196.18K 10-Q · filed 2024-11-19 | -$93.24K 10-Q · filed 2023-11-13 | -$326.44K derived: sum of 4 quarters · filed 2024-11-19 | ||||
| 2023-06-30 | -$73.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$144.47K 10-Q · filed 2024-08-14 | -$1.85K 10-Q · filed 2023-08-21 | -$274.73K derived: sum of 3 quarters · filed 2024-08-14 | -$408.41K derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | -$70.55K 10-Q · filed 2024-05-28 | -$100.39K 10-Q · filed 2023-05-22 | -$200.81K derived: sum of 2 quarters · filed 2024-05-28 | -$334.49K derived: sum of 3 quarters · filed 2024-05-28 | -$466.94K derived: sum of 4 quarters · filed 2024-05-28 | ||||
| 2022-12-31 | -$130.25K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-29 | -$263.94K derived: sum of 2 quarters · filed 2024-04-29 | -$396.39K derived: sum of 3 quarters · filed 2024-04-29 | -$446.61K 10-K · filed 2024-04-29 | |||||
| 2022-09-30 | -$133.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$266.13K derived: sum of 2 quarters · filed 2023-11-13 | -$316.35K 10-Q · filed 2023-11-13 | ||||||
| 2022-06-30 | -$132.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-21 | -$182.67K 10-Q · filed 2023-08-21 | |||||||
| 2022-03-31 | -$50.22K 10-Q · filed 2023-05-22 | ||||||||
| 2021-12-31 | $591.78K 10-K · filed 2023-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B |